Description: Genetron Holdings Limited is a leading precision oncology platform company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care.
Home Page: www.genetronhealth.com
GTH Technical Analysis
Building 11
Beijing,
102206
China
Phone:
86 10 5090 7500
Officers
| Name | Title |
|---|---|
| Mr. Sizhen Wang | Co-Founder, CEO & Chairman |
| Dr. Wei-Wu He Ph.D. | Co-Founder & Chairman Emeritus |
| Dr. Hai Yan | Co-Founder, Chief Scientific Officer & Director |
| Mr. Ce Xu | Chief Financial Officer |
| Ms. Victoria Lei | Chief Operating Officer |
| Dr. Yuchen Jiao M.D., Ph.D. | Chief Technology Officer |
| Mr. Yong Liang | Chief HR Officer |
| Dr. Yun-Fu Hu Ph.D. | Chief Medical Officer |
| Ms. Lily Liu | Chief Commercial Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.7301 |
| Price-to-Sales TTM: | 0.1771 |
| IPO Date: | 2020-06-15 |
| Fiscal Year End: | December |
| Full Time Employees: | 1154 |